Bifidobacterium animalis/lactobacillus rhamnosus Interactions
There are 351 drugs known to interact with bifidobacterium animalis/lactobacillus rhamnosus, along with 1 disease interaction. Of the total drug interactions, 351 are moderate.
- View all 351 medications that may interact with bifidobacterium animalis/lactobacillus rhamnosus
- View bifidobacterium animalis/lactobacillus rhamnosus disease interactions (1)
Most frequently checked interactions
View interaction reports for bifidobacterium animalis / lactobacillus rhamnosus and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Acetylsalicylic Acid (aspirin)
- Acidophilus (lactobacillus acidophilus)
- Adderall (amphetamine / dextroamphetamine)
- Afinitor (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aranesp (darbepoetin alfa)
- Arnuity Ellipta (fluticasone)
- Aromasin (exemestane)
- Augmentin (amoxicillin / clavulanate)
- B 100 Complex (multivitamin)
- B Complex 50 (multivitamin)
- B-Complex with B-12 (multivitamin)
- Benadryl Allergy (diphenhydramine)
- Blistex Lip Balm (emollients topical)
- CoQ10 (ubiquinone)
- D3 (cholecalciferol)
- Gas-X (simethicone)
- Ginkgo Biloba (ginkgo)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iron Sulfate (ferrous sulfate)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Xarelto (rivaroxaban)
- Zinc (zinc sulfate)
Bifidobacterium animalis/lactobacillus rhamnosus disease interactions
There is 1 disease interaction with bifidobacterium animalis / lactobacillus rhamnosus which include:
More about bifidobacterium animalis / lactobacillus rhamnosus
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.